We have located links that may give you full text access.
Adding LIT to HIIT - Is Low-Intensity Training Vital for Endurance-Trained Athletes during a 7-day HIIT Shock Microcycles?
Medicine and Science in Sports and Exercise 2024 April 9
PURPOSE: To investigate the effects of a 7-day high-intensity interval training shock microcycle (HIIT-SM) with or without additional low-intensity training (LIT) on aerobic fitness and endurance performance compared to a control group.
METHODS: Thirty-three endurance-trained athletes (7 women, 26 men, mean ± SD: age, 30.2 ± 6.9 yr; maximal oxygen uptake (V̇O2max), 59.8 ± 4.9 mL·min-1·kg-1) performed exercise testing at T1 and were randomly assigned to one of three groups: i) HSM: 10 running-based HIIT sessions (5 x 4 min at 90-95% maximal heart rate) over 7 days ii) HSM + LIT: equal to HSM with additional 30-min of LIT after each HIIT iii) CG: regular training. Exercise testing was repeated 3 days (T2), 7 days (T3), and 14 days (T4) after the intervention. A 5-km time trial (TT5km) was performed 3-4 days before T1 and 10-11 days after the intervention. Data was analyzed by two-way repeated-measures ANOVA.
RESULTS: No interaction effect was found for V̇O2max (P = 0.170, pη2 = 0.09), peak power output (P = 0.734, pη2 = 0.04), and work economy (P = 0.804, pη2 = 0.03). There was an interaction for velocity at lactate threshold (P = 0.006, pη2 = 0.18) with increased velocity in HSM at T2 (3.2%, P = 0.030), T3 (4%, P = 0.006), T4 (4%, P = 0.003), as well as in HSM + LIT for T2 (3.2%, P = 0.011), while CG showed no change. There was an interaction for TT5km (P = 0.044, pη2 = 0.19) with HSM improving 2.7% (P = 0.003), HSM + LIT 2.3% (P = 0.010), while CG was on average - 0.3% (P = 0.821) slower.
CONCLUSIONS: HIIT-SM with or without additional LIT has negligible effects on V̇O2max but improves other key endurance variables in endurance-trained athletes. No superiority of either intervention group was demonstrated. Therefore, additional LIT during HIIT-SM is not beneficial.
METHODS: Thirty-three endurance-trained athletes (7 women, 26 men, mean ± SD: age, 30.2 ± 6.9 yr; maximal oxygen uptake (V̇O2max), 59.8 ± 4.9 mL·min-1·kg-1) performed exercise testing at T1 and were randomly assigned to one of three groups: i) HSM: 10 running-based HIIT sessions (5 x 4 min at 90-95% maximal heart rate) over 7 days ii) HSM + LIT: equal to HSM with additional 30-min of LIT after each HIIT iii) CG: regular training. Exercise testing was repeated 3 days (T2), 7 days (T3), and 14 days (T4) after the intervention. A 5-km time trial (TT5km) was performed 3-4 days before T1 and 10-11 days after the intervention. Data was analyzed by two-way repeated-measures ANOVA.
RESULTS: No interaction effect was found for V̇O2max (P = 0.170, pη2 = 0.09), peak power output (P = 0.734, pη2 = 0.04), and work economy (P = 0.804, pη2 = 0.03). There was an interaction for velocity at lactate threshold (P = 0.006, pη2 = 0.18) with increased velocity in HSM at T2 (3.2%, P = 0.030), T3 (4%, P = 0.006), T4 (4%, P = 0.003), as well as in HSM + LIT for T2 (3.2%, P = 0.011), while CG showed no change. There was an interaction for TT5km (P = 0.044, pη2 = 0.19) with HSM improving 2.7% (P = 0.003), HSM + LIT 2.3% (P = 0.010), while CG was on average - 0.3% (P = 0.821) slower.
CONCLUSIONS: HIIT-SM with or without additional LIT has negligible effects on V̇O2max but improves other key endurance variables in endurance-trained athletes. No superiority of either intervention group was demonstrated. Therefore, additional LIT during HIIT-SM is not beneficial.
Full text links
Related Resources
Trending Papers
Renin-Angiotensin-Aldosterone System: From History to Practice of a Secular Topic.International Journal of Molecular Sciences 2024 April 5
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease.Rheumatology 2024 April 17
Albumin: a comprehensive review and practical guideline for clinical use.European Journal of Clinical Pharmacology 2024 April 13
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app